Rezultati pretraživanja
  1. prije 2 sata

    The approved to mitigate allergic reactions, including , that occur with exposure to . Treatment with Palforzia may be initiated in individuals ages 4-17yrs with confirmed peanut but they must continue to avoid peanuts. 🇺🇸

    2 proslijeđena tweeta
  2. prije 2 sata

    : The FDA has approved a first-of-its-kind drug to treat peanut allergies in kids. The drug, , is approved for use in kids ages 4 to 17.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  3. prije 7 sati

    First therapy for peanut allergy approved by the FDA.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  4. prije 21 sat

    “The FDA approval of is a milestone for people with ,” said Dr. Jacqueline Pongracic, MD, Division Head of Allergy and Immunology, who was Principal Investigator of Palforzia multicenter Phase 3 clinical trial.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  5. prije 24 sata

    Will Revolutionize Tx?

    1 proslijeđeni tweet
  6. 4. velj

    is the first approved treatment for patients with allergy. It is an oral immunotherapy indicated for the mitigation of allergic reactions, including , that may occur with accidental exposure to peanut.

    FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy -
  7. 3. velj

    Only some peanut allergic patients will follow this treatment. Mediterranean peanut allergic patients, usually sensitized to LTP, won't receive .

    Amazing day for as 1st FDA approved treatment for peanut allergy has arrived!🙌 Oral immunotherapy has been used by many allergists for years. Risks, benefits with this product similar to current OIT protocols. I’ll discuss with this thread⬇️
    Prikaži ovu nit
    2 proslijeđena tweeta
  8. 3. velj

    It’s not a cure, but the FDA has approved , the first medicine to treat peanut allergies, which affect roughly 3 million American

    25 proslijeđenih tweetova 49 korisnika označava da im se sviđa
  9. 3. velj

    . approves , first treatment for children

  10. 2. velj

    One of today's articles... allergy immunisation approved via drug in US Users say: 'sounds nuts to me' as the anaphylactic shock risk still remains For the FULL story, to vote and have your say go to

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
  11. 1. velj

    FDA OKs Palforzia, First Drug for Peanut Allergy in Children.

    1 korisnik označava da mu se sviđa
  12. 1. velj

    One of the allergens in , the peanut allergy drug approved by the US FDA is this one, Ara h 1:

    1 reply 10 proslijeđenih tweetova 36 korisnika označava da im se sviđa
  13. 1. velj
    Odgovor korisniku/ci

    is an FDA validated scam! the "drug" is literally just fat free peanut flour. That is, you can buy a bag of it for a few bucks in any grocery store, instead of spending thousands.

  14. 1. velj

    First drug approved by

  15. 1. velj

    FDA approves first treatment for kids with peanut allergy

    1 korisnik označava da mu se sviđa
  16. 1. velj

    Now with FDA approval, this will pave the way for more research on food allergy therapies. Stay tuned food allergy world...

    0:05
    BREAKING NEWS: We’re proud to announce FDA approval of the first treatment for . Read our release and the full Prescribing Information, including Boxed WARNING, and Medication Guide:
    Prikaži ovu nit
    2 proslijeđena tweeta 12 korisnika označava da im se sviđa
  17. 29. sij
    Odgovor korisnicima

    decision expected soon VOTE (2/2)-Are the available safety data, in conjunction with additional safeguards (under REMS), adequate to support the use of in patients aged 4 to 17 yrs with a confirmed diagnosis of peanut allergy? 8-Yes 1-No 0-Abstain

  18. 29. sij

    An FDA decision for Aimmune's is due any day, here's our previous look at the ad com meeting

    1 reply 1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.